<SEC-DOCUMENT>9999999995-21-000399-index.html : 20210204 <SEC-HEADER>9999999995-21-000399.hdr.sgml : 20210204 <ACCEPTANCE-DATETIME>20210204001524 ACCESSION NUMBER: 9999999995-21-000399 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210204 EFFECTIVENESS DATE: 20210203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-125906 FILM NUMBER: 21588677 BUSINESS ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 </SEC-HEADER> <DOCUMENT> <TYPE>EFFECT <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> </SEC-DOCUMENT>